Acquisition of majority stake in Bharat Serums and Vaccines Limited (“BSV”) by Advent International, one of the largest global private equity player
Advent International has recently acquired a majority stake in Bharat Serums and Vaccines Limited, a pharmaceutical company in India. The transaction is Advent’s seventh investment in the healthcare sector and fifth investment in India in 2019.
BSV researches, develops, manufactures and markets specialized injectable medicines with a portfolio focused on biotech and biological products. The company has multiple niche products that are leading brands across women’s health, assisted reproductive treatment, critical care and emergency medicine.
Dhruva Advisors acted as the tax and structuring advisors for the transaction to BSV.